AVTX Institutional Ownership

AVALO THERAPEUTICS INC

Latest close $19.09 as of Aug 5, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 27, 2026

Public consensus preview Accumulation leaning 62/100 institutional research score

3 tracked institutions Latest filing Jul 27, 2026

1 accumulating across 1 comparable institution.

Accumulating1

Unchanged0

Reducing0

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$4.61 52-week high$24.27

Latest close $19.09 73.7% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026

Fidelity / FMR Jun 5, 2026 filed

BlackRock Jul 27, 2026 filed

T. Rowe Price Investment Management May 15, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 6 parsed filing(s) · 3 older require more history access

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
BlackRock CIK0002012383	Jun 30, 2026 observed Jul 27, 2026 filed · 27d Initial Schedule 13G	Initial Schedule 13G	3.4M	12.00%	$18.48	$19.50	$19.09
Fidelity / FMR CIK0000315066	May 29, 2026 observed Jun 5, 2026 filed · 7d Schedule 13G amendment	Reported accumulation	3.2M +308.9K	12.00% -0.60 pts	$15.95	$13.10	$19.09
T. Rowe Price Investment Management CIK0001897612	Mar 31, 2026 observed May 15, 2026 filed · 45d Initial Schedule 13G	Initial Schedule 13G	2.2M	12.00%	$14.93	$17.74	$19.09

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

WAB WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP 62/100 Accumulation leaning SKT TANGER INC 62/100 Accumulation leaning SIDU SIDUS SPACE INC-CL A 62/100 Accumulation leaning LKFN LAKELAND FINANCIAL CORP 62/100 Accumulation leaning

Recent multi-institution accumulation

TVTX TRAVERE THERAPEUTICS INC 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026